The global Oncology Information System (OIS) market was valued at US$ 3.3 Bn in 2024 and is projected to expand at a CAGR of 7.2% from 2025 to 2035, reaching US$ 7.1 Bn by the end of 2035. The market is witnessing steady expansion due to the growing global burden of cancer and the increasing need for efficient digital systems that can streamline oncology workflows, enhance patient monitoring, and support precision treatment planning.
Access key findings and insights from our Report in this sample – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=18659
Market Overview
The Oncology Information System (OIS) market is evolving rapidly as healthcare providers transition from conventional record-keeping methods to integrated digital platforms. OIS solutions are designed to centralize patient data, treatment planning, imaging, laboratory results, and clinical workflows across radiology, medical, and surgical oncology departments.
With approximately 20 million new cancer diagnoses and 9.7 million cancer-related deaths reported globally in 2022, healthcare systems are under immense pressure to improve treatment coordination and deliver timely interventions. OIS platforms provide unified systems that monitor patient progress, automate treatment schedules, and facilitate multidisciplinary collaboration.
Key Market Growth Drivers
Rising Global Cancer Burden
The increasing incidence of cancer worldwide remains one of the strongest growth drivers for the OIS market. The complexity of oncology management—ranging from chemotherapy and radiotherapy to immunotherapy and targeted therapies—requires precise coordination and continuous monitoring. Traditional or paper-based systems are no longer sufficient to manage high patient volumes and advanced treatment regimens.
OIS solutions enable healthcare providers to efficiently manage patient records, monitor treatment cycles, and coordinate multidisciplinary care teams. These systems reduce medical errors, enhance compliance, and improve overall clinical outcomes.
Shift Toward Precision Oncology and AI-Driven Treatment
The transition toward precision oncology is significantly boosting the demand for advanced information systems. Precision oncology relies on patient-specific data such as genomic markers and molecular profiling, which must be accurately collected, processed, and analyzed.
OIS platforms integrate AI-driven analytics to support predictive modeling, decision support, and personalized treatment recommendations. These capabilities align with the global shift toward value-based care models.
Explore our report to uncover in-depth insights – https://www.transparencymarketresearch.com/oncology-information-system-market.html
Market Segmentation
The global Oncology Information System (OIS) market can be segmented based on solution and end-use applications.
By Solution:
- Software
- Services
The software segment dominates the market due to its central role in managing oncology workflows, patient data, and treatment planning. Cloud-based platforms, AI integration, and advanced analytics capabilities have further strengthened software adoption. For example, Elekta offers its OIS software “MOSAIQ,” which integrates medical oncology, radiation therapy, and patient data management into a unified platform, improving interdepartmental coordination and care delivery.
By End User:
- Hospitals
- Cancer Treatment Centers
- Research Institutes
Hospitals and specialized cancer centers account for the largest share due to increasing digital transformation initiatives and rising oncology patient volumes.
Regional Outlook
North America leads the global OIS market and is expected to maintain its dominance throughout the forecast period. The region benefits from robust healthcare IT infrastructure, early adoption of electronic health systems, and strong government support for precision medicine programs.
The presence of key market players and NCI-designated cancer centers further accelerates technology adoption. Institutions across the United States are implementing AI-driven OIS platforms that ensure interoperability between diagnostic imaging, laboratory systems, and genomic databases.
Europe continues to invest heavily in healthcare automation and integrated care models, promoting OIS adoption. Meanwhile, Asia Pacific is experiencing rapid growth driven by increased healthcare digitization investments, expanding cancer care infrastructure, and rising cancer prevalence.
Emerging economies in Asia Pacific are prioritizing digital oncology systems to improve care accessibility and efficiency, positioning the region as a high-growth market during the forecast period.
Analysis of Key Players
Leading players in the OIS market are focusing on innovation, partnerships, and geographic expansion to strengthen their market positions. Prominent companies include Varian Medical Systems, Elekta, Philips Healthcare, Cerner, Epic Systems Corporation, McKesson, Flatiron Health, Siemens Healthineers, RaySearch Laboratories, Accuray Incorporated, ViewRay, Inc., Brainlab, and Oracle.
These companies are investing in AI-enabled solutions, cloud transformation, imaging integration, and collaborative partnerships with cancer centers to enhance product capabilities. Market participants are also expanding service offerings and focusing on interoperability to align with value-based oncology care models.
Market Challenges & Opportunities
Despite strong growth prospects, the OIS market faces challenges such as high implementation costs, data privacy concerns, integration complexities with legacy systems, and the need for skilled IT personnel.
However, opportunities are substantial. The growing emphasis on digital health transformation, increasing investments in healthcare infrastructure in emerging economies, and the rising demand for cloud-based and AI-driven analytics platforms create significant expansion potential. As oncology care continues to evolve, the need for scalable, interoperable, and data-driven systems will remain critical.
Key Developments in Oncology Information System (OIS) Market
- In August 2021, Siemens Healthineers acquired Varian Medical Systems to create a unique, integrated portfolio of oncology information system workflows.
- In June 2021, Koninklijke Philips N.V. announced that it had partnered with Elekta to develop advanced, personalized cancer care through precision oncology information solutions.
Why Buy This Report?
- Comprehensive analysis of market size, growth forecasts, and industry trends through 2035
- Detailed segmentation and regional outlook
- In-depth competitive landscape and key player profiling
- Insights into technological advancements including AI and cloud integration
- Strategic intelligence to support investment and expansion decisions
Buy this Premium Research Report for exclusive, in-depth insights – https://www.transparencymarketresearch.com/checkout.php?rep_id=18659<ype=S
FAQs
- What is the current size of the Oncology Information System market?
The market was valued at US$ 3.3 Bn in 2024.
- What is the projected growth rate of the market?
It is expected to grow at a CAGR of 7.2% from 2025 to 2035.
- Which region dominates the OIS market?
North America currently leads the global market.
- Which segment holds the largest share by solution?
The software segment dominates due to its central role in oncology workflow management.
- What factors are driving market growth?
Rising global cancer incidence and the shift toward precision oncology and AI-driven treatment are the primary growth drivers.
More Trending Reports by Transparency Market Research –
Sleep Apnea Devices Market: https://www.transparencymarketresearch.com/sleep-apnea-devices-market.html
Skin Antiseptic Market: https://www.transparencymarketresearch.com/skin-antiseptic-market.html
Cancer Biomarkers Market: https://www.transparencymarketresearch.com/cancer-biomarkers-market.html
Medical Devices Outsourcing Market: https://www.transparencymarketresearch.com/medical-devices-outsourcing-market.html
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Leave a Reply